291 related articles for article (PubMed ID: 22834080)
41. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
Kiriyama A; Iga K; Shibata N
Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
[TBL] [Abstract][Full Text] [Related]
42. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
Ahmed RZ; Patil G; Zaheer Z
Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
[TBL] [Abstract][Full Text] [Related]
43. Buccal drug delivery: what's new and what does the future hold?
Giannola LI; De Caro V; Sutera FM
Ther Deliv; 2014; 5(9):965-8. PubMed ID: 25375339
[No Abstract] [Full Text] [Related]
44. Recent developments in silicones for topical and transdermal drug delivery.
Aliyar H; Schalau G
Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
[TBL] [Abstract][Full Text] [Related]
45. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
Karanth H; Shenoy VS; Murthy RR
AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
[TBL] [Abstract][Full Text] [Related]
46. Location, location, location: gastrointestinal delivery site and its impact on absorption.
Connor A
Ther Deliv; 2012 May; 3(5):575-8. PubMed ID: 22834401
[No Abstract] [Full Text] [Related]
47. Controlling subcellular delivery to optimize therapeutic effect.
Mossalam M; Dixon AS; Lim CS
Ther Deliv; 2010 Jul; 1(1):169-93. PubMed ID: 21113240
[TBL] [Abstract][Full Text] [Related]
48. Nano-formulations of drugs: Recent developments, impact and challenges.
Jeevanandam J; Chan YS; Danquah MK
Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
[TBL] [Abstract][Full Text] [Related]
49. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
50. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications.
Han J; Chen TX; Branford-White CJ; Zhu LM
Int J Pharm; 2009 Dec; 382(1-2):215-21. PubMed ID: 19660536
[TBL] [Abstract][Full Text] [Related]
51. Review: Nanopreparations for better drug delivery.
Qadir MI
Pak J Pharm Sci; 2017 Nov; 30(6):2301-2309. PubMed ID: 29175803
[TBL] [Abstract][Full Text] [Related]
52. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
53. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
54. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.
Alam MA; Ali R; Al-Jenoobi FI; Al-Mohizea AM
Expert Opin Drug Deliv; 2012 Nov; 9(11):1419-40. PubMed ID: 23043303
[TBL] [Abstract][Full Text] [Related]
55. Facile electrospinning of an efficient drug delivery system.
Mei L; Wang Y; Tong A; Guo G
Expert Opin Drug Deliv; 2016; 13(5):741-53. PubMed ID: 26787362
[TBL] [Abstract][Full Text] [Related]
56. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
Ozeki T; Tagami T
Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
[TBL] [Abstract][Full Text] [Related]
57. The dangers of generalization in nanotechnology.
Florence AT
Drug Discov Today; 2004 Jan; 9(2):60-1. PubMed ID: 15025067
[No Abstract] [Full Text] [Related]
58. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
Kumar S; Bhargava D; Thakkar A; Arora S
Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
[TBL] [Abstract][Full Text] [Related]
59. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
60. Practical considerations in development of solid dosage forms that contain cyclodextrin.
Miller LA; Carrier RL; Ahmed I
J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
